174 related articles for article (PubMed ID: 31058637)
1. Evaluation of Proliferative Marker Ki-67 in Adenoid Cystic Carcinoma: A Retrospective Study.
Bussari S; Jeergal PA; Sarode M; Namazi NA; Kulkarni PG; Deshmukh A; Kulkarni D
J Contemp Dent Pract; 2019 Feb; 20(2):211-215. PubMed ID: 31058637
[TBL] [Abstract][Full Text] [Related]
2. Management of adenoid cystic carcinoma of minor salivary glands.
Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D
J Oral Maxillofac Surg; 2006 Jul; 64(7):1114-20. PubMed ID: 16781345
[TBL] [Abstract][Full Text] [Related]
3. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma.
Beltran D; Faquin WC; Gallagher G; August M
J Oral Maxillofac Surg; 2006 Mar; 64(3):415-23. PubMed ID: 16487803
[TBL] [Abstract][Full Text] [Related]
4. Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections.
Nordgård S; Franzén G; Boysen M; Halvorsen TB
Laryngoscope; 1997 Apr; 107(4):531-6. PubMed ID: 9111386
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Expression of CD-117 (c-KIT), P-53 and Ki-67 in Adenoid Cystic Carcinoma of Palate.
Bajpai M; Pardhe N
J Coll Physicians Surg Pak; 2018 Jun; 28(6):S130-S132. PubMed ID: 29866247
[TBL] [Abstract][Full Text] [Related]
6. High podoplanin and low E-cadherin levels correlate with better prognosis in adenoid cystic carcinoma.
van der Wal JE; Sgaramella N; Norberg Spaak L; Zborayova K; Nylander K
Clin Exp Dent Res; 2019 Aug; 5(4):350-355. PubMed ID: 31452946
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.
Maiorano E; Favia G; Pece S; Resta L; Maisonneuve P; Di Fiore PP; Capodiferro S; Urbani U; Viale G
Int J Immunopathol Pharmacol; 2007; 20(4):779-89. PubMed ID: 18179751
[TBL] [Abstract][Full Text] [Related]
8. P53 and Ki-67 antigen expression in small oral biopsy specimens of salivary gland tumors.
Lazzaro B; Cleveland D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 May; 89(5):613-7. PubMed ID: 10807720
[TBL] [Abstract][Full Text] [Related]
9. Study of MYB-NFIB chimeric gene expression, tumor angiogenesis, and proliferation in adenoid cystic carcinoma of salivary gland.
Ono J; Okada Y
Odontology; 2018 Jul; 106(3):238-244. PubMed ID: 29243184
[TBL] [Abstract][Full Text] [Related]
10. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
11. Expression of the membrane-cytoskeletal linker Ezrin in salivary gland adenoid cystic carcinoma.
Wang YY; Chen WL; Huang ZQ; Yang ZH; Zhang B; Wang JG; Li HG; Li JS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jul; 112(1):96-104. PubMed ID: 21550270
[TBL] [Abstract][Full Text] [Related]
12. High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma.
Vékony H; Raaphorst FM; Otte AP; van Lohuizen M; Leemans CR; van der Waal I; Bloemena E
J Clin Pathol; 2008 Jun; 61(6):744-9. PubMed ID: 18326020
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Detection of Proliferative Marker Ki-67 in Benign and Malignant Salivary Gland Tumors.
Bussari S; Ganvir SM; Sarode M; Jeergal PA; Deshmukh A; Srivastava H
J Contemp Dent Pract; 2018 Apr; 19(4):375-383. PubMed ID: 29728539
[No Abstract] [Full Text] [Related]
14. Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas.
Lin YC; Chen KC; Lin CH; Kuo KT; Ko JY; Hong RL
Int J Oral Maxillofac Surg; 2012 Mar; 41(3):354-60. PubMed ID: 22230288
[TBL] [Abstract][Full Text] [Related]
15. Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis.
Tang QL; Fan S; Li HG; Chen WL; Shen XM; Yuan XP; Chang SH; Song Y
Oral Oncol; 2011 May; 47(5):365-70. PubMed ID: 21439895
[TBL] [Abstract][Full Text] [Related]
16. Ataxia-Telangiectasia-Mutated Protein Expression as a Prognostic Marker in Adenoid Cystic Carcinoma of the Salivary Glands.
Bazarsad S; Kim JY; Zhang X; Kim KY; Lee DY; Ryu MH; Kim J
Yonsei Med J; 2018 Aug; 59(6):717-726. PubMed ID: 29978608
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical features of lacrimal gland epithelial tumors.
Mendoza PR; Jakobiec FA; Krane JF
Am J Ophthalmol; 2013 Dec; 156(6):1147-1158.e1. PubMed ID: 23972314
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland tumors: immunohistochemical study of EGF, EGFR, ErbB-2, FAS and Ki-67.
Ito FA; Ito K; Coletta RD; Graner E; de Almeida OP; Lopes MA
Anal Quant Cytol Histol; 2009 Oct; 31(5):280-7. PubMed ID: 20701095
[TBL] [Abstract][Full Text] [Related]
19. Assessment of proliferative activity using the MIB1 antibody help to distinguish polymorphous low grade adenocarcinoma from adenoid cystic carcinoma of salivary glands.
Skálová A; Simpson RH; Lehtonen H; Leivo I
Pathol Res Pract; 1997; 193(10):695-703. PubMed ID: 9505262
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of DNA topoisomerase type II alpha and Ki-67 in adenoid cystic carcinoma and pleomorphic adenoma of the salivary gland.
Hirabayashi S
J Oral Pathol Med; 1999 Mar; 28(3):131-6. PubMed ID: 10069542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
